vasculotide

N/A

Report date: 2025/03/20 09:20:34

Base Information

Drug Namevasculotide
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTEK receptor tyrosine kinase agonistsGrowth factor receptors modulators
TargetsGrowth factor receptorsTEK receptor tyrosine kinase
Therapy Area/IndicationsWounds and InjuriesDiabetic FootRenal Insufficiency +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSunnybrook Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesAnges IncVasomune Therapeutics Inc
Inactive CompaniesSunnybrook Research InstituteToronto Innovation Acceleration Partners
Active IndicationsRenal InsufficiencyRespiratory Distress Syndrome, Adult
Inactive IndicationsWounds and InjuriesDiabetic FootAlzheimer Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A